Micro Emerging Active

Heron Therapeutics, Inc. (HRTX) Stock Recovery Opportunity

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
1
Sources
1

Sentiment Timeline

Event Timeline

Jun 30, 2026
Is Heron Therapeutics, Inc. (HRTX) Stock a Recovery Opportunity After Cinvanti Patent … Neutral

Hypotheses

Pending Due: Oct. 28, 2026

HRTX institutional ownership will increase by minimum 5 percentage points within 120 days as recovery narrative attracts investment funds following patent litigation resolution.

Pending Due: Oct. 28, 2026

HRTX revenue from Cinvanti product line will increase by minimum 20% quarter-over-quarter following patent court resolution, demonstrating market confidence restoration.

Pending Due: Sept. 28, 2026

HRTX stock will recover above $15 per share within 90 days following positive patent court ruling outcomes or settlement announcements related to Cinvanti intellectual property disputes.

Timeline

Last UpdatedJun 30, 2026